Clinical Trials Logo

Bacterial Infection clinical trials

View clinical trials related to Bacterial Infection.

Filter by:

NCT ID: NCT02794831 Completed - Bacterial Infection Clinical Trials

Exposure to NSAIDs (Non Steroidal Anti-Inflammatory Drugs) and Severity of Community-acquired Bacterial Infections

ANAIG
Start date: September 22, 2016
Phase:
Study type: Observational

- NSAIDs are widely consumed, and some are currently available for self-medication with indications 'Pain and Fever' (Cavalié, National Agency for Drug Safety (ANSM), 2014) - There is no recommendation to limit their use in bacterial infections except for chicken pox in children. - To date, no study has highlighted the aggravating role of exposure to NSAIDs on bacterial infections in adults, based on the usual septic severity Levy's score (SSS), and mortality, but it delays adequate antibiotics (Legras, Critical Care, 2009) - Community-acquired bacterial infections in adults exposed to NSAIDs are serious by their spread (multiple locations), and suppurative character requiring frequent use of invasive procedures such as surgery or drainage. The SSS does not reflect the seriousness of these infections. They are frequently associated with use of ibuprofen (63.4%), and self-medication practices (65.5%). The main hypothesis is that NSAIDs exposure is associated with a specific severity of community-acquired bacterial infection, marked by dissemination, suppurative complications or even invasive procedures requirement. Our objectives are also to: - Describe what NSAID use terms are associated to the risk of serious bacterial infections: molecule, dosage, duration of exposure, access (prescription or self-medication), associated drugs. - To determine what type (s) (s) of bacterial infection is worsened by exposure to NSAIDs. - To determine if other risk factors contribute to severity of bacterial community acquired infection - To describe hospital costs associated to such severity of bacterial infection

NCT ID: NCT02753387 Completed - Bacterial Infection Clinical Trials

Effect of Oral Preparation on Bacterial Colonization of the Pharyngeal Mucosa in Surgery of Head and Neck Cancer

ORAL-ISO
Start date: May 23, 2016
Phase: Phase 3
Study type: Interventional

Surgical site infections are an important health indicator for hospitals and a significant medico-economic issue. The aim of the study is to assess the impact of chlorhexidine mouthwash performed before surgery on the bacterial colonization of the pharyngeal mucosa.

NCT ID: NCT02598141 Completed - Bacterial Infection Clinical Trials

Grinding Versus Standard Methods for the Treatment of Per-operative Bacteriological Samples Associated With Osteo-articular Sepsis

IOAP Turrax
Start date: May 18, 2016
Phase: N/A
Study type: Interventional

The main objective of this study was to compare the diagnostic capability (sensitivity and specificity) of standard bacteriological analysis made from one or other of the two sampling processing techniques and perioperative management of samples : the Ultra Turrax method that uses grinding versus the standard method.

NCT ID: NCT02544230 Completed - Sepsis Clinical Trials

Granulocyte Transfusions in Hematological Patients With Febrile Neutropenia

Start date: January 2004
Phase: N/A
Study type: Observational

The investigators retrospectively evaluated the efficacy of granulocyte transfusions as adjunctive treatment for severe infections in neutropenic fever unresponsive to antimicrobial therapy in hematological patients.

NCT ID: NCT02533609 Active, not recruiting - Acute Kidney Injury Clinical Trials

Elimination of Antibiotics During Citrate-anticoagulated Continuous-veno-venous-haemodialysis

DIADSORBMAB
Start date: September 2015
Phase:
Study type: Observational

Acute kidney injury (AKI) requiring renal replacement therapy is common in critically ill patients. The major causes of AKI are severe sepsis and septic shock requiring effective antibiotic treatment. Patients with sepsis on ICUs usually are haemodynamically instable so that renal replacement therapy is applied using continuous techniques. In recent years, the efficacy of renal replacement therapies has improved, namely by using regional citrate anticoagulation which improves filter lifetime and filter patency. At present, the extent of removal of antibiotic drugs using citrate-anticoagulated CVVHD in critically ill patients has not been investigated thoroughly. Thus, the investigators want to investigate 1. whether and to what extent antibiotic drugs (piperacillin/tazobactam and imipenem/cilastatin) are removed during citrate-anticoagulated CVVHD per se 2. whether filter patency during citrate-anticoagulated CVVD remains stable during a treatment period of 72 h

NCT ID: NCT02436876 Completed - Bacterial Infection Clinical Trials

Study to Assess Safety and Clinical Activity of Local MBN-101 in Treatment of Infected Bone Sites

Start date: May 24, 2016
Phase: Phase 2
Study type: Interventional

This study evaluates the safety and clinical benefit of MBN-101 administered intraoperatively to osteosynthesis or osteomyelitis sites for patients diagnosed with an orthopedic infection, with or without orthopaedic hardware. Three quarters of the patients will receive MBN-101, while the other one quarter will receive placebo.

NCT ID: NCT02375477 Completed - Clinical trials for Clostridium Difficile

Improved Adherence to C. Difficile Isolation Protocols Through Improved Education Methods

Start date: January 27, 2015
Phase: N/A
Study type: Interventional

This clinical trial studies how well inter-disciplinary educational methods work in improving adherence to isolation protocols in patients with Clostridium (C.) difficile infections. An inter-disciplinary educational method may help to prevent the spread of infection.

NCT ID: NCT02311816 Completed - Bacterial Infection Clinical Trials

Increase in Procalcitonin Kinetics May be a Good Indicator of Starting Empirical Antibiotic Treatment in Critically Ill Patients

Start date: October 2012
Phase: N/A
Study type: Observational

The value of procalcitonin change from the day before to the day when infection was suspected in predicting bacterial infection in intensive care patients.

NCT ID: NCT02294175 Completed - Bacterial Infection Clinical Trials

Larval Debridement Therapy Versus Sharp Debridement to Remove Biofilm

Start date: January 2015
Phase: N/A
Study type: Interventional

This is a prospective study of Veterans with chronic lower extremity or diabetic foot ulcers who will be randomized to either a Larval Debridement Therapy group (Biobags every 4 days x 2 applications) or a Sharp Debridement Therapy group (standard or control weekly x 2) during an 8 day study period.

NCT ID: NCT02268279 Completed - Bacterial Infection Clinical Trials

Pharmacokinetics and Safety of Solithromycin in Adolescents and Children

Start date: January 2015
Phase: Phase 1
Study type: Interventional

Pediatric study to evaluate the safety and pharmacokinetics of solithromycin (oral and intravenous) in children ages 0 to 17